Zhao T, Chen H, Cheng C, Zhang J, Yan Z, Kuang J, Kong F, Li C, Lu Q
The 503A pathway for patient-specific compounding by state-licensed pharmacies remains available under a narrower framework, requiring that the prescriber document a "significant difference" justifying why the compounded version meets the specific patient's medical need in a way the FDA-approved product cannot
Activa Anlisis del GLP-1
If you've been following the medical weight loss conversation, you already know that injectable drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have fundamentally changed how medicine approaches obesity and metabolic health
Drinking large amounts of water may keep you hydrated, but it does not make the medication leave faster
We do not have a good handle on GLP-1 receptor agonists and their impact on systemic levels of oral contraceptives